Literature DB >> 12173325

Prognostic value of nuclear grading in patients with intracapsular (pT1-pT2) renal cell carcinoma. Long-term analysis in 213 patients.

Andrea Minervini1, Leon Lilas, Riccardo Minervini, Cesare Selli.   

Abstract

BACKGROUND: The TNM classification system considers tumor size and, in particular tumor, greatest dimension as the only prognostic indicator for intracapsular renal cell carcinoma (RCC). The objective of the current study was to evaluate the role of nuclear grading and its importance as a prognostic indicator in patients with intracapsular (T1-T2) RCC.
METHODS: A retrospective study was performed on 213 patients with RCC limited to the kidney who were free from distant metastases at the time of diagnosis and who underwent radical nephrectomy from January 1990 to November 1999. All patients were staged according to the 1997 TNM classification system. Nuclear grading was determined according to the criteria proposed by Fuhrman et al. The patients' status was evaluated last in November 2000. The mean follow-up was 52 months (range, 12-130 months). The probability of survival was estimated by using the Kaplan-Meier method, with the long-rank test used to estimate differences among levels of the analyzed variables. A multivariate Cox proportional hazards model was performed to estimate the relative importance of the variables in predicting survival.
RESULTS: The 5-year disease specific survival rates for patients with pT1 and pT2 tumors were 93.5% and 61.1%, respectively. The 5-year disease specific survival rates for patients with Grade 1, Grade 2, and Grade 3-4 tumors were 95.9%, 86.8%, and 60.1%, respectively. A comparison of the survival curves both by stage and grade showed a statistically significant difference. For patients with pT1 lesions, the 5-year disease specific survival rate was 94.2% for patients with Grade 1-2 disease and 89.8% for patients with Grade 3-4 disease. For patients with pT2 lesions, the 5-year disease specific survival rate was 72.2% for patients with Grade 1-2 disease and 20% for patients with Grade 3-4 disease.
CONCLUSIONS: Within intracapsular tumors that measure > 7.0 cm in greatest dimension, nuclear grade is an important morphologic variable for predicting long-term survival. Identification of patients with nuclear Grade 3-4 tumors is important prognostically to determine the metastatic potential of pT2 tumors, because this subgroup of patients may benefit from adjuvant immunotherapy.

Entities:  

Mesh:

Year:  2002        PMID: 12173325     DOI: 10.1002/cncr.10510

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT.

Authors:  Nicolas Aide; Olivier Cappele; Philippe Bottet; Henri Bensadoun; Armelle Regeasse; François Comoz; Franck Sobrio; Gérard Bouvard; Denis Agostini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-04       Impact factor: 9.236

2.  VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma.

Authors:  Francesca Lessi; Chiara Maria Mazzanti; Sara Tomei; Claudio Di Cristofano; Andrea Minervini; Michele Menicagli; Alessandro Apollo; Lorenzo Masieri; Paola Collecchi; Riccardo Minervini; Marco Carini; Generoso Bevilacqua
Journal:  Med Oncol       Date:  2014-01-21       Impact factor: 3.064

3.  The Prognostic Factors for Patients with pT1a Renal Cell Carcinoma.

Authors:  Jong Min Kim; Phil Hyun Song; Hyun Tae Kim; Tong Choon Park
Journal:  Korean J Urol       Date:  2010-04-20

4.  Prediction models for clear cell renal cell carcinoma ISUP/WHO grade: comparison between CT radiomics and conventional contrast-enhanced CT.

Authors:  Dong Han; Yong Yu; Nan Yu; Shan Dang; Hongpei Wu; Ren Jialiang; Taiping He
Journal:  Br J Radiol       Date:  2020-08-12       Impact factor: 3.039

5.  Association between nuclear grade of renal cell carcinoma and the aorta-lesion-attenuation-difference.

Authors:  Joseph R Grajo; Nikhil V Batra; Shahab Bozorgmehri; Laura L Magnelli; Padraic O'Malley; Russell Terry; Li-Ming Su; Paul L Crispen
Journal:  Abdom Radiol (NY)       Date:  2021-08-31

6.  Prognostic factors and survival of renal clear cell carcinoma patients with bone metastases.

Authors:  Attila Szendroi; Elek Dinya; Magdolna Kardos; A Marcel Szász; Zsuzsanna Németh; Katalin Ats; János Kiss; Imre Antal; Imre Romics; Miklós Szendroi
Journal:  Pathol Oncol Res       Date:  2009-07-29       Impact factor: 3.201

7.  MicroRNAs as Urinary Biomarker for Oncocytoma.

Authors:  Melanie von Brandenstein; Monika Schlosser; Jan Herden; Axel Heidenreich; Stefan Störkel; Jochen W U Fries
Journal:  Dis Markers       Date:  2018-07-16       Impact factor: 3.464

8.  Partial nephrectomy and positive surgical margin, oncologic outcomes and predictors: a 15-year single institution experience.

Authors:  Mohammad Hadi Radfar; Fatemeh Ameri; Mehdi Dadpour; Reza Khabazian; Nasrin Borumandnia; Sajjad Askarpour Kabir
Journal:  Cent European J Urol       Date:  2021-12-06

Review 9.  Surgical margins after partial nephrectomy as prognostic factor for the risk of local recurrence in pT1 RCC: a systematic review and narrative synthesis.

Authors:  Michaël M E L Henderickx; Suraj V Baldew; Axel Bex; Patricia J Zondervan; Lorenzo Marconi; Marcel D van Dijk; Faridi S van Etten-Jamaludin; Brunolf W Lagerveld
Journal:  World J Urol       Date:  2022-05-03       Impact factor: 3.661

10.  Reassessment of American Joint Committee on Cancer Staging for Stage III Renal Cell Carcinoma With Nodal Involvement: Propensity Score Matched Analyses of a Large Population-Based Study.

Authors:  Jianglong Han; Qin Li; Ping Li; Shijie Wang; Rui Zhang; Yunfeng Qiao; Qibin Song; Zhenming Fu
Journal:  Front Oncol       Date:  2020-03-19       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.